Statin use-breastcancer, statiner-bröstcancer studie

 

Gästinlägg:

 

Jag blir mörkrädd. Trots att det tom står i bipacksedeln att man inte ska ge statiner till kvinnor 75+ år, så gör man det.

Statiner, kassakon för Big Pharma.

This study was published in Cancer Epidemiology Biomarkers and Prevention 2007 Mar;16(3):416-21

 

Study title and authors:

Statin use and breast cancer risk in a large population-based setting.

Boudreau DM, Yu O, Miglioretti DL, Buist DS, Heckbert SR, Daling JR.

Group Health, Center for Health Studies, Suite 1600, 1730 Minor Avenue, Seattle, WA 98101, USA. boudreau.d@ghc.org

 

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/17372235

The objective of the study was to evaluate the relationship between statin use and breast cancer risk. The study included 92,788 women, aged 45 to 89, who were followed for 6.4 years.

The study found:
(a) Statin users had a 7.4% inceased risk of breast cancer compared to non users.
(b) A longer duration of statin use led to an increased risk of breast cancer:
(i) Statin use of three to 4.9 years was associated with a 4% increased risked of breast cancer.
(ii) Statin use of over five years was associated with a 27% increased risked of breast cancer.

The data from the study shows that statin use is associated with an increased risk of breast cancer, and the longer the duration of statin use - the higher the risk of breast cancer.